Tirzepatide
Dual GIP / GLP-1 agonist.
A dual agonist engaging both the GIP and GLP-1 receptors — a leading subject of current incretin-based metabolic research.
Purity
≥99% (HPLC)
Presentations
10 mg · 20 mg · 30 mg
Format
Research use only
Tirzepatide · RD-15In research terms
How it's
understood.
Simultaneously activates GIP and GLP-1 receptors, studied for additive effects on insulin sensitivity, satiety and lipid metabolism.
Descriptions summarise published research context only. Nothing here is dosing guidance or a claim of any effect in humans.
Where it's studied
Dual-incretin signalling models
Glucose and lipid metabolism
Body-composition research
Research use only
For laboratory research. Not for human consumption.
Tirzepatide is supplied to researchers and institutions for in-vitro and laboratory study. Need a certificate of analysis or handling detail for Tirzepatide? Get in touch.
Request documentation →Related compounds
View all →
All products listed are supplied strictly for laboratory and research use only. They are not dietary supplements, medicines or foods, and are not intended for human or veterinary consumption, diagnosis or treatment. This website is informational and does not offer products for sale.